monitor [hlca]    
Complex [chvs]    
Serum [bdsu]    
Liver disease [dsyn]    
progress [patf]    
patient [podg]    
Hepatitis, Chronic [dsyn]    
patient [podg]    
Hepatitis, Chronic [dsyn]    
Progressive liver disease [fndg]    
One [qnco]    
Most [qnco]    
Issue [fndg]    
detect [topp]    
Non-invasive [ftcn]    
Marker [clna]    
Fibrosis stage [clna]    
Disease Progression [patf]    
High [qlco]    
Level [qlco]    
Hepatocellular carcinoma [neop]    
Increase [ftcn]    
Cirrhotic [qlco]    
patient [podg]    
Tumor [neop]    
development [phsf]    
low [qlco]    
Percentage [qnco]    
patient [podg]    
Hepatitis, Chronic [dsyn]    
Aim [idcn]    
studies [mnob]    
To [qlco]    
Assess [acty]    
Complex [chvs]    
Disease Outcome [fndg]    
Group [idcn]    
patient [podg]    
ELISA assay [lbpr]    
used [fndg]    
To [qlco]    
Presence [topp]    
patient [podg]    
Hepatitis, Chronic [dsyn]    
Control [grup]    
Addition [ftcn]    
Serum sample [bdsu]    
Available [ftcn]    
median [spco]    
period [tmco]    
year [tmco]    
untreated [fndg]    
patient [podg]    
patient [podg]    
a group [clas]    
include [ftcn]    
Eight [qnco]    
patient [podg]    
Fibrosis score [clna]    
Increase [ftcn]    
+2 [qnco]    
Second [qnco]    
Liver Biopsy [diap]    
Group [idcn]    
include [ftcn]    
patient [podg]    
Fibrosis [patf]    
progress [patf]    
Similar [qlco]    
Follow-up [fndg]    
Complex [chvs]    
patient [podg]    
Control [grup]    
Significance [qnco]    
Increase [ftcn]    
Squamous cell carcinoma antigen level [lbpr]    
Time [tmco]    
Observation [ftcn]    
patient [podg]    
Fibrosis [patf]    
progress [patf]    
Mean [qnco]    
SD [fndg]    
U/ml [qnco]    
year [tmco]    
Not [ftcn]    
Without [qlco]    
Histologic [ftcn]    
deteriorate [phpr]    
Mean [qnco]    
SD [fndg]    
31 [inpr]    
/mL [qnco]    
year [tmco]    
Conclusion [idcn]    
monitor [hlca]    
Squamous cell carcinoma antigen level [lbpr]    
Time [tmco]    
APPEAR [qlco]    
use [ftcn]    
Approach [spco]    
patient [podg]    
Hepatitis, Chronic [dsyn]    
High Risk [qlco]    
Cirrhosis [dsyn]    
development [phsf]    
